ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasms

被引：0
|
作者：
Hassan Awada
Manasa Bhatta
Han Yu
Wenyan Ji
Surui Hou
Tara Cronin
Sheeba Ba Aqeel
Arya Mariam Roy
Muhammad Salman Faisal
Peter Kouides
John Mascarenhas
Elizabeth A. Griffiths
Amro Elshoury
机构：
[1] Roswell Park Comprehensive Cancer Center,Benign Hematology & Leukemia Service, Department of Medicine
[2] The Mount Sinai Hospital,Department of Medicine
[3] Roswell Park Comprehensive Cancer Center,Department of Biostatistics & Bioinformatic
[4] Virginia Polytechnic Institute and State University,Department of Medicine, Rochester Regional Health
[5] Center for Biostatistics and Health Data Science,Tisch Cancer Institute, Division of Hematology/Oncology
[6] Rochester General Hospital,undefined
[7] Icahn School of Medicine at Mount Sinai,undefined
[8] Western New York BloodCare,undefined
来源：
Leukemia | 2024年 / 38卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：210 / 214
页数：4
相关论文
共 50 条
  • [1] ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasms
    Awada, Hassan
    Bhatta, Manasa
    Yu, Han
    Ji, Wenyan
    Hou, Surui
    Cronin, Tara
    Ba Aqeel, Sheeba
    Roy, Arya Mariam
    Faisal, Muhammad Salman
    Kouides, Peter
    Mascarenhas, John
    Griffiths, Elizabeth A.
    Elshoury, Amro
    [J]. LEUKEMIA, 2024, 38 (01) : 210 - 214
  • [2] ASXL1 Mutation Is a Novel Risk Factor for Bleeding in Patients with Philadelphia-Negative Myeloproliferative Neoplasms (MPN)
    Elshoury, Amro
    Yu, Han
    Ji, Wenyan
    Thompson, James E.
    Griffiths, Elizabeth A.
    Przespolewski, Amanda
    Green, Steven Daniel
    Sung, Pamela J.
    Aqeel, Sheebaba
    Awada, Hassan
    Wang, Eunice S.
    Kouides, Peter A.
    [J]. BLOOD, 2021, 138
  • [3] PLATELET COUNT AS A RISK FACTOR FOR HEMORRHAGIC COMPLICATIONS IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
    Simonovic, E.
    Macukanovic-Golubovic, L.
    Colic, V.
    [J]. HAEMATOLOGICA, 2016, 101 : 815 - 815
  • [4] Smoking and philadelphia-negative chronic myeloproliferative neoplasms
    Sorensen, Anders Lindholm
    Hasselbalch, Hans Carl
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (01) : 63 - 69
  • [5] Serum procalcitonin in Philadelphia-negative myeloproliferative neoplasms
    Krecak, Ivan
    Peran, Nena
    Lapic, Ivana
    Gveric-Krecak, Velka
    Krecak, Filip
    Roncevic, Pavle
    Durakovic, Nadira
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (1-2) : 62 - 64
  • [6] Serum procalcitonin in Philadelphia-negative myeloproliferative neoplasms
    Ivan Krečak
    Nena Peran
    Ivana Lapić
    Velka Gverić-Krečak
    Filip Krečak
    Pavle Rončević
    Nadira Duraković
    [J]. Wiener klinische Wochenschrift, 2021, 133 : 62 - 64
  • [7] Inflammatory picture of Philadelphia-negative myeloproliferative neoplasms
    Barbosa Pagnano, Katia Borgia
    [J]. HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2018, 40 (02) : 101 - 102
  • [8] Molecular characterization of Philadelphia-negative myeloproliferative neoplasms
    Brisci, Angela
    Pietra, Daniela
    Foglieni, Barbara
    Boggi, Sabrina
    Rumi, Elisa
    Passamonti, Francesco
    Ferrari, Maurizio
    Cremonesi, Laura
    [J]. BIOCHIMICA CLINICA, 2010, 34 (02) : 110 - 114
  • [9] Mutations of ASXL1 gene in myeloproliferative neoplasms
    N Carbuccia
    A Murati
    V Trouplin
    M Brecqueville
    J Adélaïde
    J Rey
    W Vainchenker
    O A Bernard
    M Chaffanet
    N Vey
    D Birnbaum
    M J Mozziconacci
    [J]. Leukemia, 2009, 23 : 2183 - 2186
  • [10] Age at diagnosis is an important prognostic factor in Philadelphia-negative Myeloproliferative Neoplasms
    Accurso, Vincenzo
    Santoro, Marco
    Siragusa, Sergio
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 103 (02) : 140 - 141
12345